Article Text

Download PDFPDF
Genetic testing for maturity onset diabetes of the young in childhood hyperglycaemia

Abstract

Mild hyperglycaemia is a common finding during minor illness in children. The differential diagnosis includes maturity onset diabetes of the young (MODY), which can be a difficult diagnosis to make clinically. As most genes resulting in MODY have been identified, it is possible to make a firm diagnosis using mutation detection. A case is reported of a 4 year old girl in whom a diagnosis of MODY2 was established by the finding of a heterozygous missense mutation in exon 7 of the glucokinase gene, resulting in the substitution at codon 259 of alanine by threonine (A259T). Observations from other glucokinase families suggest that hyperglycaemia in this child is likely to be stable and will not require intensive medical follow up, whereas other forms of MODY (1, 3, and 4) might carry a different prognosis.

  • Maturity onset diabetes of the young is an important diagnosis to consider in a child with incidental hyperglycaemia.

  • If considered, parents’ fasting blood glucose should be measured. If raised, molecular genetic testing may be useful.

  • Molecular genetic testing has defined four different phenotypes of MODY with different clinical courses and prognoses.

  • MODY2, resulting in defects of the glucokinase gene, carries a good prognosis.

  • maturity onset diabetes of the young
  • hyperglycaemia
  • DNA sequencing
  • mutation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes